staurosporine has been researched along with Neurodegenerative Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, KH; Dhorma, LP; Hah, JM; Kim, MH; Kim, SY; Kumar, DN; Park, HG; Venkanna, A | 1 |
| Blunt, M; Craggs, P; Hardwick, P; Hobbs, CI; Rowland, P; Shillings, A; Singh, O; Skarzynski, T; Smith, KJ; Tanner, R; Wall, I; Witty, DR | 1 |
| Bandyopadhyay, U; Cuervo, AM; Figliola, M; Gauthier, S; Grubb, A; Kumar, AR; Levy, E; Mohan, P; Nixon, RA; Pawlik, M; Sahoo, S; Tizon, B; Uchiyama, Y; Yu, H | 1 |
| Heinrich, M; Kaltschmidt, B; Kaltschmidt, C | 1 |
| Cheng, T; Fernández, JA; Gelbard, H; Griffin, JH; Guo, H; Insalaco, R; Liu, D; Zlokovic, BV | 1 |
| Alonso, M; Cortes-Canteli, M; Luna-Medina, R; MartÃnez, A; Perez-Castillo, A; Santos, A | 1 |
| Boustany, RM; Guo, WX; Nikbakht, K; Puranam, KL; Qian, WH | 1 |
| Cheetham, M; Fridlanskaya, I; Guzhova, I; Kislyakova, K; Margulis, B; Moskaliova, O; Tytell, M | 1 |
| Ahlemeyer, B; Klumpp, S; Krieglstein, J | 1 |
| Fiander, H; O'Reilly, N; Small, DL; Tauskela, J; Xia, Z | 1 |
10 other study(ies) available for staurosporine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone.
Topics: Drug Discovery; Inflammation; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Nitric Oxide; Protein Kinase Inhibitors; Quinones; Spiro Compounds; Structure-Activity Relationship | 2019 |
Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design.
Topics: Binding Sites; Cardiovascular Diseases; Crystallography, X-Ray; Drug Design; Humans; Ligands; MAP Kinase Kinase Kinase 5; Neoplasms; Neurodegenerative Diseases; Sf9 Cells; Signal Transduction; Staurosporine | 2013 |
Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines.
Topics: Adenine; Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line; Colchicine; Cystatin C; Enzyme Inhibitors; Lysosomes; Mice; Neurodegenerative Diseases; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley; Staurosporine; TOR Serine-Threonine Kinases; Tubulin Modulators | 2010 |
Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells.
Topics: Amyloid beta-Peptides; Animals; Anthracenes; Apoptosis; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hydroxyl Radical; Iron; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Perylene; Protein Kinase C; Rats; Rats, Wistar; Staurosporine | 2002 |
Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Caspases; Cells, Cultured; Cerebral Cortex; Fetus; Flavoproteins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Protein C; Receptor, PAR-1; Receptors, Thrombin; Staurosporine; Tumor Suppressor Protein p53 | 2004 |
Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation.
Topics: Alitretinoin; Anilides; Animals; Anti-Inflammatory Agents; Apoptosis; Astrocytes; Brain; Cell Death; Cell Line; Cell-Free System; Cells, Cultured; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Immunohistochemistry; In Vitro Techniques; Inflammation; Interleukin-6; Lipopolysaccharides; Lithium Chloride; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Models, Chemical; Neurodegenerative Diseases; Neuroglia; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rats; Staurosporine; Thiazolidinediones; Time Factors; Transfection; Tretinoin; Tumor Necrosis Factor-alpha | 2005 |
CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
Topics: Apoptosis; Blotting, Western; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Ceramides; Cyclins; Dose-Response Relationship, Drug; Etoposide; Humans; Membrane Glycoproteins; Models, Biological; Molecular Chaperones; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae Proteins; Sphingosine; Staurosporine; Time Factors; Transfection; Vincristine | 1999 |
In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance.
Topics: Adenosine Triphosphate; Apoptosis; Carcinogens; Cell Differentiation; Cell Survival; Central Nervous System; Enzyme Inhibitors; Heat-Shock Response; HSP70 Heat-Shock Proteins; Humans; Immunohistochemistry; Models, Biological; Neurodegenerative Diseases; Neurofilament Proteins; Neuroglia; Neurons; Phorbol Esters; Staurosporine; Stress, Physiological; Tumor Cells, Cultured | 2001 |
Release of cytochrome c into the extracellular space contributes to neuronal apoptosis induced by staurosporine.
Topics: Animals; Animals, Newborn; Antibodies; Apoptosis; Cell Differentiation; Cell Membrane; Cell Membrane Permeability; Cells, Cultured; Central Nervous System; Chick Embryo; Cytochrome c Group; Cytosol; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Space; Hippocampus; L-Lactate Dehydrogenase; Mitochondria; Neurodegenerative Diseases; Neurons; Rats; Rats, Inbred F344; Staurosporine | 2002 |
Disparity between ionic mediators of volume regulation and apoptosis in N1E 115 mouse neuroblastoma cells.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Apoptosis; Bumetanide; Cell Membrane; Cell Size; Central Nervous System; Chloride Channels; Enzyme Inhibitors; Furosemide; Ion Channels; Mice; Neuroblastoma; Neurodegenerative Diseases; Neurons; Niflumic Acid; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Staurosporine; Tumor Cells, Cultured | 2002 |